Pituitary & hypothalamus

Prevalence and clinical associations of USP8 variants in corticotroph tumours: a systematic review and aggregate data meta-analysis of 2171 cases

Eur J EndocrinolPublished Systematic review and meta-analysis

Authors' conclusion

The present meta-analysis shows that patients with USP8 variant tumours are mostly female, diagnosed at younger age, more likely to achieve postoperative remission, but at a higher risk of recurrence than those with tumours carrying the reference allele.

Study context

Population
Original studies including ≥5 patients with CD reporting genetic USP8 status; functional and silent/non-functioning corticotroph tumours; PubMed, Embase, Web of Science
Participants
2,171 participants44 studies
Comparison
USP8 variant vs reference allele corticotroph tumours
  • USP8 variantsn = 692
Outcome
Prevalence of USP8 variants
Methodological detailsrandom-effects model, meta-regression, aggregate data
  • Random-effects model
  • Meta-regression
  • Aggregate data

Pooled result

As reported in the abstract

Pooled prevalence of USP8 variants

Pooled prevalence

31.1%

95% CI 26.5%–36.0%

Prevalence in functional tumours

34.1%

95% CI 29.4%–39.1%

Further pooled results

Prevalence of USP8 variants in functional tumours

Pooled prevalence, functional tumours (higher than overall)
34.1% (95% CI, 29.4%-39.1%)

Female sex

Patients with USP8 variants mostly female, OR
4.52 (95% CI, 3.39-6.02)

Postoperative remission

USP8 status associated with higher odds of postoperative remission, OR
1.76 (95% CI, 1.18-2.63)

Recurrence

USP8 status associated with higher odds of recurrence, OR
2.38 (95% CI, 1.03-5.48)

Age at diagnosis

Patients with USP8 variants younger at diagnosis on average (years)
4.47 (95% CI, 2.28-6.65 years younger)

Other clinical or tumour variables

No clear evidence of association with any other clinical or tumour variable, mostly due to heterogeneity among studies

Meta-regression of variability in USP8 variant prevalence

Related to female/male ratio, adjusted R2
0.301
Not related to other variables, such as tumour size or invasion

Original publication

Prevalence and clinical associations of USP8 variants in corticotroph tumours: a systematic review and aggregate data meta-analysis of 2171 cases. Eur J Endocrinol. Published 20 May 2025. doi:10.1093/ejendo/lvaf097

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.